Los Angeles Capital Management LLC Makes New $14.27 Million Investment in Axon Enterprise, Inc. (NASDAQ:AXON)

Los Angeles Capital Management LLC purchased a new stake in shares of Axon Enterprise, Inc. (NASDAQ:AXONFree Report) during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 55,250 shares of the biotechnology company’s stock, valued at approximately $14,273,000. Los Angeles Capital Management LLC owned approximately 0.07% of Axon Enterprise at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. Natixis Advisors L.P. increased its position in shares of Axon Enterprise by 16.3% in the 4th quarter. Natixis Advisors L.P. now owns 24,792 shares of the biotechnology company’s stock valued at $6,404,000 after acquiring an additional 3,468 shares during the period. Ashburton Jersey Ltd increased its holdings in shares of Axon Enterprise by 6.9% in the fourth quarter. Ashburton Jersey Ltd now owns 15,307 shares of the biotechnology company’s stock valued at $3,954,000 after purchasing an additional 988 shares during the period. Trinity Financial Advisors LLC purchased a new position in shares of Axon Enterprise in the fourth quarter worth about $204,000. Triumph Capital Management acquired a new stake in shares of Axon Enterprise during the fourth quarter worth about $253,000. Finally, Brighton Jones LLC purchased a new stake in Axon Enterprise in the fourth quarter valued at approximately $203,000. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have issued reports on AXON shares. Morgan Stanley raised their price target on shares of Axon Enterprise from $285.00 to $310.00 and gave the stock an “equal weight” rating in a research report on Friday, April 26th. JMP Securities boosted their target price on shares of Axon Enterprise from $320.00 to $375.00 and gave the company a “market outperform” rating in a research report on Wednesday. Needham & Company LLC reaffirmed a “buy” rating and set a $400.00 price target on shares of Axon Enterprise in a research report on Wednesday, April 24th. StockNews.com lowered Axon Enterprise from a “buy” rating to a “hold” rating in a research note on Thursday, March 14th. Finally, The Goldman Sachs Group upped their target price on Axon Enterprise from $297.00 to $339.00 and gave the stock a “buy” rating in a research note on Wednesday, February 28th. Two investment analysts have rated the stock with a hold rating and ten have given a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $323.09.

View Our Latest Stock Report on Axon Enterprise

Axon Enterprise Price Performance

AXON stock traded up $1.80 during trading on Friday, hitting $318.55. The stock had a trading volume of 279,175 shares, compared to its average volume of 468,981. Axon Enterprise, Inc. has a twelve month low of $175.37 and a twelve month high of $329.87. The company’s 50-day moving average price is $308.83 and its two-hundred day moving average price is $264.98. The company has a debt-to-equity ratio of 0.42, a current ratio of 3.00 and a quick ratio of 2.66. The stock has a market capitalization of $24.04 billion, a P/E ratio of 138.50 and a beta of 0.91.

Axon Enterprise (NASDAQ:AXONGet Free Report) last posted its quarterly earnings data on Tuesday, February 27th. The biotechnology company reported $0.77 EPS for the quarter, beating the consensus estimate of $0.48 by $0.29. Axon Enterprise had a return on equity of 14.11% and a net margin of 11.14%. The firm had revenue of $432.14 million during the quarter, compared to the consensus estimate of $418.97 million. As a group, research analysts predict that Axon Enterprise, Inc. will post 2.44 EPS for the current fiscal year.

Axon Enterprise Profile

(Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Featured Stories

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXONFree Report).

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.